Qiagen NV | QIA - Interest Expense On Debt

Stock Price
35.69
Daily Change
-0.06 -0.17%
Monthly
-14.10%
Yearly
-1.76%
Q1 Forecast
35.13

Qiagen NV reported $10.14M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Akebia Therapeutics 364.15M 18.56M Sep/2025
Alaunos Therapeutics USD 0 0 Dec/2023
argenx SE USD 828K 165K Dec/2025
Avita Medical AUD 1.25M 100K Jun/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Ionis Pharmaceuticals USD 18M 0 Dec/2025
IQVIA Holdings USD 193M 4M Dec/2025
Moderna USD 12.14B 12.13B Sep/2025
Organon & Co USD 128M 3M Sep/2025
Qiagen NV USD 10.14M 1.92M Dec/2025
Revvity USD 23.51M 742K Dec/2025
Tectonic Therapeutic USD 277M 276.98M Sep/2025
Viatris USD 119.6M 0 Dec/2025
Xeris Pharmaceuticals USD 7.27M 92K Sep/2025